DK1026263T3 - Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf - Google Patents
Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse derafInfo
- Publication number
- DK1026263T3 DK1026263T3 DK00300792T DK00300792T DK1026263T3 DK 1026263 T3 DK1026263 T3 DK 1026263T3 DK 00300792 T DK00300792 T DK 00300792T DK 00300792 T DK00300792 T DK 00300792T DK 1026263 T3 DK1026263 T3 DK 1026263T3
- Authority
- DK
- Denmark
- Prior art keywords
- hiv
- methods
- reverse transcription
- oligonucleotide primers
- effective detection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- AIDS & HIV (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11841799P | 1999-02-02 | 1999-02-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1026263T3 true DK1026263T3 (da) | 2008-09-08 |
Family
ID=22378462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00300792T DK1026263T3 (da) | 1999-02-02 | 2000-02-01 | Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf |
Country Status (13)
Country | Link |
---|---|
US (1) | US6303293B1 (ja) |
EP (1) | EP1026263B1 (ja) |
JP (1) | JP2000342274A (ja) |
KR (1) | KR100901084B1 (ja) |
CN (1) | CN1186455C (ja) |
AT (1) | ATE397099T1 (ja) |
AU (1) | AU761066B2 (ja) |
CA (1) | CA2295920C (ja) |
DE (1) | DE60038993D1 (ja) |
DK (1) | DK1026263T3 (ja) |
ES (1) | ES2306648T3 (ja) |
NO (1) | NO327727B1 (ja) |
PT (1) | PT1026263E (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8036741B2 (en) | 1996-04-30 | 2011-10-11 | Medtronic, Inc. | Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure |
US6479523B1 (en) * | 1997-08-26 | 2002-11-12 | Emory University | Pharmacologic drug combination in vagal-induced asystole |
EP1198271A4 (en) | 1999-06-25 | 2009-01-21 | Univ Emory | DEVICES AND METHODS FOR STIMULATING THE VAGUSNERVS |
US6623920B1 (en) * | 1999-07-09 | 2003-09-23 | Gen-Probe Incorporated | Detection of HIV-1 by nucleic acid amplification |
CA2318730C (en) * | 1999-09-20 | 2008-01-22 | Ortho-Clinical Diagnostics, Inc. | A method for reverse transcribing rna isolated in dry form |
DE60132924T2 (de) | 2000-10-23 | 2009-03-05 | Gen-Probe Inc., San Diego | Zusammensetzungen und methoden zur detektion von humanem immundefizienz virus 2 (hiv-2) |
EP2251442B9 (en) * | 2003-12-19 | 2012-04-25 | Gen-Probe Incorporated | Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2 |
CN100340673C (zh) * | 2005-02-03 | 2007-10-03 | 上海科华生物工程股份有限公司 | 人类免疫缺陷病毒hiv-1核酸扩增-荧光定量检测试剂盒 |
GB0701253D0 (en) | 2007-01-23 | 2007-02-28 | Diagnostics For The Real World | Nucleic acid amplification and testing |
EP3187585A1 (en) | 2010-03-25 | 2017-07-05 | Oregon Health&Science University | Cmv glycoproteins and recombinant vectors |
US8639327B2 (en) | 2010-04-29 | 2014-01-28 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
US8423134B2 (en) | 2010-04-29 | 2013-04-16 | Medtronic, Inc. | Therapy using perturbation and effect of physiological systems |
US8620425B2 (en) | 2010-04-29 | 2013-12-31 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
US8706223B2 (en) | 2011-01-19 | 2014-04-22 | Medtronic, Inc. | Preventative vagal stimulation |
US8781583B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
US8718763B2 (en) | 2011-01-19 | 2014-05-06 | Medtronic, Inc. | Vagal stimulation |
US8725259B2 (en) | 2011-01-19 | 2014-05-13 | Medtronic, Inc. | Vagal stimulation |
US8781582B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
DK2691530T3 (en) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | CMV GLYCOPROTEIN AND RECOMBINANT VECTORS |
EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
CN104066842A (zh) * | 2012-01-25 | 2014-09-24 | 独立行政法人科学技术振兴机构 | Hiv检测用寡核苷酸、hiv检测试剂盒及hiv检测方法 |
EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
EP2848937A1 (en) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Methods of identifying novel HIV-1 immunogens |
EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
ES2800474T3 (es) * | 2014-05-27 | 2020-12-30 | Univ Paris Descartes | Método in vitro para la detección y la cuantificación del VIH-2 |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
AU2017301881A1 (en) * | 2016-07-29 | 2019-02-07 | Juno Therapeutics, Inc. | Methods for assessing the presence or absence of replication competent virus |
CA3035808A1 (en) * | 2016-09-07 | 2018-03-15 | St Vincent's Hospital Sydney Limited | Methods of detecting lentivirus |
CN106498095A (zh) * | 2016-11-14 | 2017-03-15 | 湖南圣湘生物科技有限公司 | 一种人类免疫性缺陷病毒2型核酸检测试剂盒 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69034220T2 (de) | 1989-06-02 | 2006-12-28 | Institut Pasteur | Nukleotid-Sequenzen von HIV-1, HIV-2 and SIV Retrovirusgenommen, ihre Verwendung zur Amplifizierung von diesen Retrovieren und zur in vitro Diagnostik von diesen Viren verursachten Infektion |
US5478724A (en) | 1991-08-16 | 1995-12-26 | The Rockefeller University | Lentivirus-specific nucleotide probes and methods of use |
AU677225B2 (en) | 1992-10-06 | 1997-04-17 | Dade Behring Marburg Gmbh | Retrovirus from the HIV group and its use |
US5599662A (en) * | 1995-02-17 | 1997-02-04 | Hoffmann-La Roche Inc. | Oliconucleotide primers and probes for the detection of HIV-1 |
US5962665A (en) | 1997-06-16 | 1999-10-05 | Abbott Laboratories | Nucleic acid primers and probes for detecting HIV-1 and HIV-2 |
US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
-
2000
- 2000-01-28 US US09/494,102 patent/US6303293B1/en not_active Expired - Lifetime
- 2000-02-01 AU AU14829/00A patent/AU761066B2/en not_active Ceased
- 2000-02-01 DK DK00300792T patent/DK1026263T3/da active
- 2000-02-01 EP EP00300792A patent/EP1026263B1/en not_active Expired - Lifetime
- 2000-02-01 NO NO20000513A patent/NO327727B1/no not_active IP Right Cessation
- 2000-02-01 PT PT00300792T patent/PT1026263E/pt unknown
- 2000-02-01 CA CA2295920A patent/CA2295920C/en not_active Expired - Fee Related
- 2000-02-01 DE DE60038993T patent/DE60038993D1/de not_active Expired - Lifetime
- 2000-02-01 ES ES00300792T patent/ES2306648T3/es not_active Expired - Lifetime
- 2000-02-01 AT AT00300792T patent/ATE397099T1/de active
- 2000-02-02 KR KR1020000005148A patent/KR100901084B1/ko not_active IP Right Cessation
- 2000-02-02 JP JP2000025419A patent/JP2000342274A/ja active Pending
- 2000-02-02 CN CNB001053973A patent/CN1186455C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE397099T1 (de) | 2008-06-15 |
KR20010014470A (ko) | 2001-02-26 |
NO327727B1 (no) | 2009-09-14 |
ES2306648T3 (es) | 2008-11-16 |
EP1026263A3 (en) | 2000-10-11 |
CN1186455C (zh) | 2005-01-26 |
DE60038993D1 (de) | 2008-07-10 |
EP1026263B1 (en) | 2008-05-28 |
AU1482900A (en) | 2000-08-03 |
EP1026263A2 (en) | 2000-08-09 |
JP2000342274A (ja) | 2000-12-12 |
CA2295920A1 (en) | 2000-08-02 |
NO20000513D0 (no) | 2000-02-01 |
CN1271020A (zh) | 2000-10-25 |
AU761066B2 (en) | 2003-05-29 |
CA2295920C (en) | 2013-10-29 |
NO20000513L (no) | 2000-08-03 |
KR100901084B1 (ko) | 2009-06-08 |
PT1026263E (pt) | 2008-08-27 |
US6303293B1 (en) | 2001-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1026263T3 (da) | Oligonukleotidprimere til omvendt transkription til effektiv detektering af HIV-1 og HIV-2 og fremgangsmåder til anvendelse deraf | |
DK1026262T3 (da) | Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf | |
DK0887427T3 (da) | Amplifikation og detektion af HIV-1 og/eller HIV-2 | |
FR16C0028I2 (fr) | Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques | |
TR199701669A1 (xx) | Deri preparasyonu i�in bile�imler. | |
DK1515752T3 (da) | ACE2-aktivering til behandling af hjerte-, lunge- og nyresygdomme og hypertension | |
DK1334194T3 (da) | Afbildning, diagnosticering og behandling af sygdom | |
DE60041489D1 (de) | Nachweis von hiv-1 durch amplifizierung von nukleinsäuren | |
DK1313462T3 (da) | Anvendelse af asiatisk syre eller asiaticosid til behandling af cancer | |
NO20000514D0 (no) | Oligonukleotidprimere for effektiv multipleks deteksjon av Hepatitis C-virus (HCV) og human immunmangelvirus (HIV) og metoder for anvendelse derav | |
WO2002022076A3 (en) | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids | |
WO2007002172A3 (en) | Hiv-1 protease inhibitors | |
WO2002099387A3 (en) | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids | |
DE60229624D1 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion | |
WO2002022781A3 (en) | Non-nucleoside reverse transcriptase inhibitor as antiretroviral therapy | |
FR2834717B1 (fr) | Mutants de la proteine tat du virus vih-1 | |
WO2004016228A3 (en) | HTLV-I p30II AND p12I PROTEINS AS THERAPEUTIC TARGETS IN HTVL-I INFECTED INDIVIDUALS | |
DE69426574D1 (de) | Makrocyclische difluorostatonderivate als antivirale mittel | |
CY1108543T1 (el) | Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv |